Xoma | XOMA - Pre Tax Profit


Xoma reported $15.98M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Agenus USD -10.61M 263.52M Dec/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Ardelyx USD -400K 467K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Curis USD 19.36M 33.34M Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Novartis USD 5.17B 637M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Prothena USD -21.58M 15.33M Dec/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Xoma USD 15.98M 24.58M Jun/2024